… psoriasis that are known to increase the risk of reactivation of TBC infection. In our study, there
were no cases of active TBC or TBC reactivation among 59 psoriasis patients … %) patients …

… patients undergoing IT in which no viral reactivation was observed. Only one case of HCV
reactivation during treatment with ustekinumab for psoriasis is reported in the literature [25]. …

… Because these agents lack direct hepatic or renal toxicity, 3 … ) reactivation following
TNF-α–inhibitor use in patients with … the safety of all biologics in psoriasis patients exposed to HBV …

… the context of psoriasis. 10, 11, 12, 13, 14 However, studies on predictors for HBVr and HCVr
in patients with psoriasis treated with biologics in a real-world setting are lacking. Moreover…

… , further complicate the risk assessment of TB reactivation in psoriatic patients treated with
biologics (9). The percentage of psoriatic patients with LTBI in Europe is approximately 20%, …

… TB reactivation. Although not included in our systematic review, we found no case reports
of TB reactivation in patients treated with IL-17 inhibitors. A limitation of our study is a lack of …

… has been reported in patients with diseases other than psoriasis treated with … reactivation
in patients with a past history of HBV infection who were receiving biologic therapy for psoriasis…

… of hepatitis B virus (HBV) reactivation among psoriasis patients with varying HBV status who
… the lack of any breach of patient privacy. Adult patients with moderate-to-severe psoriasis …

… patients with psoriasis are at high risk of virus reactivation when … HBV reactivation and serious
complications in HBsAg-positive … The lack of antiviral treatment in these individuals would …

… of psoriasis, including T-cell activation, T-cell trafficking from the circulation into the skin, and
T-cell reactivation … be selected for patients who discontinued efalizumab because of lack of …